Bupropion
Bupropion is a pharmaceutical drug with 149 clinical trials. Currently 8 active trials ongoing. Historical success rate of 90.0%.
Success Metrics
Based on 108 completed trials
Phase Distribution
Phase Distribution
37
Early Stage
30
Mid Stage
59
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.0%
108 of 127 finished
15.0%
19 ended early
8
trials recruiting
149
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
Contingency Management for Smoking Cessation in Homeless Smokers
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants
Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants
Clinical Trials (149)
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
Contingency Management for Smoking Cessation in Homeless Smokers
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants
Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants
A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity
Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants
The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette
Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Metabolism-informed Care for Smoking Cessation
Combination of Novel Therapies for CKD Comorbid Depression
CPT-SMART for Treatment of PTSD and Cigarette Smoking
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Study of Injectable Naltrexone and Oral Bupropion Among Cigarette Smokers With Schizophrenia
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness
A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants
Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 149